Analysis | Metabolite Name | Measured Value | Units | stress | treatment |
---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M-H)- | 1740 | Peak area | N | None |
Reversed phase NEGATIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M-H)- | 3058 | Peak area | Y | +Lacto |
Reversed phase NEGATIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M-H)- | 3114 | Peak area | Y | None |
Reversed phase NEGATIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M-H)- | 3530 | Peak area | Y | None |
Reversed phase NEGATIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M-H)- | 4115 | Peak area | Y | None |
Reversed phase NEGATIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M-H)- | 4830 | Peak area | N | None |
Reversed phase NEGATIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M-H)- | 6612 | Peak area | Y | +Lacto |
Reversed phase NEGATIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M-H)- | 7421 | Peak area | Y | +Lacto |
Reversed phase NEGATIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M-H)- | 8467 | Peak area | N | None |
Reversed phase NEGATIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M-H)- | 8858 | Peak area | Y | None |
Reversed phase NEGATIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M-H)- | 17301 | Peak area | N | None |
Reversed phase NEGATIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M-H)- | Peak area | N | None | |
Reversed phase NEGATIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M-H)- | Peak area | Y | +Lacto | |
Reversed phase NEGATIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M-H)- | Peak area | Y | None | |
Reversed phase POSITIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M+H)+ | 19770 | Peak area | Y | +Lacto |
Reversed phase POSITIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M+H)+ | 31702 | Peak area | N | None |
Reversed phase POSITIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M+H)+ | 41938 | Peak area | Y | +Lacto |
Reversed phase POSITIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M+H)+ | 42115 | Peak area | Y | None |
Reversed phase POSITIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M+H)+ | 46063 | Peak area | Y | +Lacto |
Reversed phase POSITIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M+H)+ | 47235 | Peak area | N | None |
Reversed phase POSITIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M+H)+ | 48476 | Peak area | Y | None |
Reversed phase POSITIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M+H)+ | 60094 | Peak area | N | None |
Reversed phase POSITIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M+H)+ | 60116 | Peak area | Y | None |
Reversed phase POSITIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M+H)+ | 62896 | Peak area | Y | None |
Reversed phase POSITIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M+H)+ | 68829 | Peak area | Y | None |
Reversed phase POSITIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M+H)+ | 70258 | Peak area | Y | +Lacto |
Reversed phase POSITIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M+H)+ | 72471 | Peak area | N | None |
Reversed phase POSITIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M+H)+ | 73842 | Peak area | N | None |
Reversed phase POSITIVE ION MODE | OPHTHALMIC ACID (CAS# 495-27-2); (M+H)+ | 77325 | Peak area | Y | +Lacto |